All companies
Visit website
ALLEVIATE
OperatingAlleviate, Inc.
Healthcare · Founded 2020
The future of physical therapy
Post-money valuation ⓘ
$15.0M
As of Sep 2024 · from Alleviate Preferred Stock 1 · pre-money + amount raised, not a traded price
Total raised
$12,836
Across 1 round since 2024
Latest share price
$1.33
Alleviate Preferred Stock 1 offering price
Financials
FY2022–FY2023 · from SEC filings · hover any figure for its source$158K
−$1.2M
2022
$494K
−$2.1M
2023
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2022
FY2023
Income statement
Revenue
$158,012
$494,423
Cost of goods sold
$353,687
$399,814
Gross margin
-124%
19%
Net income
-$1,211,600
-$2,097,390
Taxes paid
$0
$0
Balance sheet
Cash
$147,030
$327,585
Accounts receivable
$26,334
$46,329
Total assets
$655,462
$585,895
Short-term debt
$2,280,000
$690,262
Long-term debt
$70,025
$222,334
Total liabilities
$2,350,025
$912,596
Other
Headcount
—
7
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$15.0M
post-money
Alleviate Preferred Stock 1
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $12.8K / $1.2MInvestors 25Post-money $15M
Reg CF annual-report compliance
Not obligated
never closed a Reg CF raise
25 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
Source: ManualCIK 0001920047Share price $1.33
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.